お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:先進創傷ケアの世界市場 - 業界動向と予測 (2028年まで)
市場調査レポート
商品コード
997285

先進創傷ケアの世界市場 - 業界動向と予測 (2028年まで)

Global Advanced Wound Care Market - Industry Trends and Forecast to 2028

出版日: | 発行: Data Bridge Market Research Private Limited | ページ情報: 英文 459 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.15円
先進創傷ケアの世界市場 - 業界動向と予測 (2028年まで)
出版日: 2021年02月01日
発行: Data Bridge Market Research Private Limited
ページ情報: 英文 459 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の先進創傷ケア市場は、2021年~2028年の予測期間中にCAGRで6.3%の成長が予測されています。

当レポートでは、世界の先進創傷ケア市場について調査分析し、市場概要、セグメント別の市場分析、地域別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 市場セグメンテーション

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 世界の先進創傷ケア市場:法規制

第6章 市場概要

  • 促進要因
  • 抑制要因
  • 機会
  • 課題

第7章 世界の先進創傷ケア市場に対するCOVID-19の影響

    • COVID-19の余波と政府の役割
  • 市場シェアを獲得するためのCOVID-19後のメーカー向け戦略的意思決定
  • 価格への影響
  • サプライチェーンへの影響
  • 需要への影響
  • 結論

第8章 世界の先進創傷ケア市場:製品タイプ別

  • 概要
  • ドレッシング
    • フォームドレッシング
    • フィルムドレッシング
    • アルギン酸ドレッシング
    • 抗菌薬
    • ハイドロゲルドレッシング
    • コラーゲンドレッシング。
    • ポリアクリレートドレッシング
    • 超吸収ドレッシング
    • 創傷接触層
    • 創傷洗浄剤
    • ハニードレッシング
  • 治療デバイス
    • 陰圧創傷治療 (NPWT)
    • 理学療法
    • 圧力除去デバイス
    • 高圧酸素室
    • 創傷デブリードマンデバイス
  • バイオ医薬品
    • 同種移植片
    • 異種移植片
    • 合成皮膚片
    • 増殖因子
  • その他

第9章 世界の先進創傷ケア市場:創傷クラス別

  • 概要
  • クラスIII
  • クラスIV
  • クラスII
  • クラスI

第10章 世界の先進創傷ケア市場:創傷タイプ別

  • 概要
  • 一次創傷ケア
  • 二次創傷ケア

第11章 世界の先進創傷ケア市場:エンドユーザー別

  • 概要
  • 病院
  • 創傷ケアセンター
  • 外来センター
  • 在宅医療
  • クリニック
  • その他

第12章 世界の先進創傷ケア市場:流通チャネル別

  • 概要
  • 直接入札
  • 小売

第13章 世界の先進創傷ケア市場:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • オランダ
    • スイス
    • ベルギー
    • トルコ
    • その他の欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • オーストラリア
    • 韓国
    • インド
    • インドネシア
    • タイ
    • シンガポール
    • マレーシア
    • フィリピン
    • その他のアジア太平洋地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • エジプト
    • イスラエル
    • その他の中東・アフリカ

第14章 世界の先進創傷ケア市場:企業情勢

  • 企業シェア分析:世界
  • 企業シェア分析:北米
  • 企業シェア分析:欧州
  • 企業シェア分析:アジア太平洋地域

第15章 SWOT分析

第16章 企業プロファイル

  • SMITH & NEPHEW
  • 3M
  • MEDLINE INDUSTRIES, INC.
  • MOLNLYCKE HEALTH CARE AB
  • CONVATEC GROUP PLC
  • BAXTER
  • CARDINAL HEALTH
  • B. BRAUN MELSUNGEN AG
  • BRIGHTWAKE LTD.
  • COLOPLAST GROUP
  • DERMARITE INDUSTRIES, LLC
  • ELKEM ASA
  • ESSITY AKTIEBOLAG
  • HOLLISTER INCORPORATED
  • INTEGRA LIFESCIENCES CORPORATION
  • JOHNSON & JOHNSON SERVICES, INC.
  • KERECIS
  • LOHMANN & RAUSCHER GMBH & CO. KG
  • MEDTRONIC
  • MIMEDX
  • ORGANOGENESIS INC.
  • HARTMANN USA, INC. (A SUBSIDIARY OF PAUL HARTMANN AG)
  • TRIAGE MEDITECH PVT. LTD.
  • ZIMMER BIOMETCOMPANY

第17章 アンケート

第18章 関連レポート

図表

LIST OF FIGURES

  • FIGURE 1 GLOBAL ADVANCED WOUND CARE MARKET: SEGMENTATION 60
  • FIGURE 2 GLOBAL ADVANCED WOUND CARE MARKET: DATA TRIANGULATION 63
  • FIGURE 3 GLOBAL ADVANCED WOUND CAREMARKET: DROC ANALYSIS 64
  • FIGURE 4 GLOBAL ADVANCED WOUND CARE MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 65
  • FIGURE 5 GLOBAL ADVANCED WOUND CARE MARKET: COMPANY RESEARCH ANALYSIS 65
  • FIGURE 6 GLOBAL ADVANCED WOUND CARE MARKET: INTERVIEW DEMOGRAPHICS 66
  • FIGURE 7 GLOBAL ADVANCED WOUND CARE MARKET: DBMR MARKET POSITION GRID 67
  • FIGURE 8 GLOBAL ADVANCED WOUND CARE MARKET: DBMR VENDOR SHARE ANALYSIS 69
  • FIGURE 9 GLOBAL ADVANCED WOUND CARE MARKET: MARKET END USER COVERAGE GRID 72
  • FIGURE 10 GLOBAL ADVANCED WOUND CARE MARKET: SEGMENTATION 76
  • FIGURE 11 INCREASING CASES OF CHRONIC WOUNDS IS EXPECTED TO DRIVE THE GLOBAL ADVANCED WOUND CARE MARKET IN THE FORECAST PERIOD OF 2021 TO 2028 77
  • FIGURE 12 DRESSING SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL ADVANCED WOUND CARE MARKET IN 2021 & 2028 77
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL ADVANCED WOUND CARE MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028 78
  • FIGURE 14 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR ADVANCED WOUND CARE MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028 79
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL ADVANCED WOUND CARE MARKET 86
  • FIGURE 16 TOP TEN COUNTRIES/TERRITORIES FOR NUMBER OF NEW CASES OF TYPE 1 DIABETES (CHILDREN AND ADOLESCENTS <20 YEARS), PER YEAR 87
  • FIGURE 17 HEALTHCARE EXPENDITURE IN FEW COUNTRIES (2016 & 2019) 92
  • FIGURE 18 GLOBAL ADVANCED WOUND CARE MARKET: BY PRODUCT TYPE, 2020 104
  • FIGURE 19 GLOBAL ADVANCED WOUND CARE MARKET: BY PRODUCT TYPE, 2020-2028 (USD MILLION) 105
  • FIGURE 20 GLOBAL ADVANCED WOUND CARE MARKET: BY PRODUCT TYPE, CAGR (2020-2028) 105
  • FIGURE 21 GLOBAL ADVANCED WOUND CARE MARKET: BY PRODUCT TYPE, LIFELINE CURVE 106
  • FIGURE 22 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND CLASS, 2020 120
  • FIGURE 23 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND CLASS, 2020-2028 (USD MILLION) 121
  • FIGURE 24 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND CLASS, CAGR (2020-2028) 121
  • FIGURE 25 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND CLASS, LIFELINE CURVE 122
  • FIGURE 26 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND TYPE, 2020 127
  • FIGURE 27 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND TYPE, 2020-2028 (USD MILLION) 128
  • FIGURE 28 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND TYPE, CAGR (2020-2028) 128
  • FIGURE 29 GLOBAL ADVANCED WOUND CARE MARKET: BY WOUND TYPE, LIFELINE CURVE 129
  • FIGURE 30 GLOBAL ADVANCED WOUND CARE MARKET: BY END USER, 2020 135
  • FIGURE 31 GLOBAL ADVANCED WOUND CARE MARKET: BY END USER, 2020-2028 (USD MILLION) 136
  • FIGURE 32 GLOBAL ADVANCED WOUND CARE MARKET: BY END USER, CAGR (2020-2028) 136
  • FIGURE 33 GLOBAL ADVANCED WOUND CARE MARKET: BY END USER, LIFELINE CURVE 137
  • FIGURE 34 GLOBAL ADVANCED WOUND CARE MARKET: BY DISTRIBUTION CHANNEL, 2020 143
  • FIGURE 35 GLOBAL ADVANCED WOUND CARE MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION) 144
  • FIGURE 36 GLOBAL ADVANCED WOUND CARE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028) 144
  • FIGURE 37 GLOBAL ADVANCED WOUND CARE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 145
  • FIGURE 38 GLOBAL ADVANCED WOUND CARE MARKET: SNAPSHOT (2020) 150
  • FIGURE 39 GLOBAL ADVANCED WOUND CARE MARKET: BY COUNTRY (2020) 151
  • FIGURE 40 GLOBAL ADVANCED WOUND CARE MARKET: BY COUNTRY (2020 & 2028) 151
  • FIGURE 41 GLOBAL ADVANCED WOUND CARE MARKET: BY COUNTRY (2020 & 2028) 152
  • FIGURE 42 GLOBAL ADVANCED WOUND CARE MARKET: BY TYPE (2020-2028) 152
  • FIGURE 43 NORTH AMERICA ADVANCED WOUND CARE MARKET : SNAPSHOT (2020) 154
  • FIGURE 44 NORTH AMERICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020) 155
  • FIGURE 45 NORTH AMERICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 155
  • FIGURE 46 NORTH AMERICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 156
  • FIGURE 47 NORTH AMERICA ADVANCED WOUND CARE MARKET : BY TYPE (2020-2028) 156
  • FIGURE 48 EUROPE ADVANCED WOUND CARE MARKET : SNAPSHOT (2020) 181
  • FIGURE 49 EUROPE ADVANCED WOUND CARE MARKET : BY COUNTRY (2020) 182
  • FIGURE 50 EUROPE ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 182
  • FIGURE 51 EUROPE ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 183
  • FIGURE 52 EUROPE ADVANCED WOUND CARE MARKET : BY TYPE (2020-2028) 183
  • FIGURE 53 ASIA-PACIFIC ADVANCED WOUND CARE MARKET : SNAPSHOT (2020) 252
  • FIGURE 54 ASIA-PACIFIC ADVANCED WOUND CARE MARKET : BY COUNTRY (2020) 253
  • FIGURE 55 ASIA-PACIFIC ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 253
  • FIGURE 56 ASIA-PACIFIC ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 254
  • FIGURE 57 ASIA-PACIFIC ADVANCED WOUND CARE MARKET : BY TYPE (2020-2028) 254
  • FIGURE 58 SOUTH AMERICA ADVANCED WOUND CARE MARKET : SNAPSHOT (2020) 323
  • FIGURE 59 SOUTH AMERICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020) 324
  • FIGURE 60 SOUTH AMERICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 324
  • FIGURE 61 SOUTH AMERICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 325
  • FIGURE 62 SOUTH AMERICA ADVANCED WOUND CARE MARKET : BY TYPE (2020-2028) 325
  • FIGURE 63 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET : SNAPSHOT (2020) 345
  • FIGURE 64 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020) 346
  • FIGURE 65 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 346
  • FIGURE 66 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET : BY COUNTRY (2020 & 2028) 347
  • FIGURE 67 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET : BY TYPE (2020-2028) 347
  • FIGURE 68 GLOBAL ADVANCED WOUND CARE MARKET: COMPANY SHARE 2020 (%) 385
  • FIGURE 69 NORTH AMERICA ADVANCED WOUND CARE MARKET: COMPANY SHARE 2020 (%) 386
  • FIGURE 70 EUROPE ADVANCED WOUND CARE MARKET: COMPANY SHARE 2020 (%) 387
  • FIGURE 71 ASIA-PACIFIC ADVANCED WOUND CARE MARKET: COMPANY SHARE 2020 (%) 388
目次

Global advanced wound care market is projected to register a CAGR of 6.3% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028

Market Segmentation:

Global Advanced Wound Care Market, By Product Type (Dressing, Therapy Device, Biologics, Others), Wound Type (Primary Wound Care, Secondary Wound Care), Wound Class (Class I, Class II, Class III, Class IV), End User (Hospitals, Wound Care Centers, Ambulatory Centers, Home Healthcare, Clinics, Others), Distribution Channel (Direct Tenders, Retail), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey & Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific , Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

Some of the major factors contributing to the growth of global advanced wound care market are:

  • Increasing cases of chronic wounds
  • Increasing number of patients undergoing surgical procedures

Market Players:

The key market players for global advanced wound care market are listed below:

  • Smith & Nephew
  • 3M
  • Medline Industries, Inc.
  • Molnlycke Health Care AB
  • ConvaTec Group PLC
  • Baxter
  • Cardinal Health
  • Lohmann & Rauscher GmbH & Co. KG
  • HARTMANN USA, Inc. (a subsidiary of PAUL HARTMANN AG)
  • MiMedx
  • Johnson & Johnson Services, Inc.
  • Integra LifeSciences Corporation
  • Essity Aktiebolag
  • Coloplast Group
  • Organogenesis Inc.
  • B. Braun Melsungen AG
  • Medtronic
  • Hollister Incorporated
  • Zimmer Biomet
  • Elkem ASA
  • TRIAGE MEDITECH PVT. LTD.
  • Brightwake Ltd.
  • DermaRite Industries, LLC
  • Kerecis

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL ADVANCED WOUND CARE MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 DBMR MARKET POSITION GRID
  • 2.8 DBMR VENDOR SHARE ANALYSIS
  • 2.9 MULTIVARIATE MODELING
  • 2.10 PRODUCT TYPE TIMELINE CURVE
  • 2.11 MARKET END USER COVERAGE GRID
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 GLOBAL ADVANCED WOUND CARE MARKET: LAWS AND REGULATIONS

6 MARKET OVERVIEW

  • 6.1 DRIVERS
    • 6.1.1 INCREASING CASES OF CHRONIC WOUNDS
    • 6.1.2 NEW PRODUCT LAUNCHES
    • 6.1.3 INCREASING NUMBER OF PATIENTS UNDERGOING SURGICAL PROCEDURES
    • 6.1.4 GROWING GERIATRIC POPULATION
    • 6.1.5 RISING AWARENESS PROGRAMS
    • 6.1.6 INCREASING RESEARCH AND DEVELOPMENT
  • 6.2 RESTRAINTS
    • 6.2.1 HIGH COST ASSOCIATED WITH THE TREATMENT
    • 6.2.2 STRINGENT MANUFACTURING POLICIES
    • 6.2.3 PRODUCT RECALL
  • 6.3 OPPORTUNITIES
    • 6.3.1 TECHNOLOGICAL ADVANCEMENT IN WOUND CARE
    • 6.3.2 GROWTH POTENTIAL IN EMERGING ECONOMIES
    • 6.3.3 STRATEGIC INITIATIVES BY THE COMPANIES
  • 6.4 CHALLENGES
    • 6.4.1 LACK OF SKILLED LABOR FORCE
    • 6.4.2 SIDE EFFECTS AND ADVERSE EFFECTS ASSOCIATED WITH CHRONIC WOUNDS
    • 6.4.3 IMPROPER REIMBURSEMENT SCENARIO

7 IMPACT OF COVID-19 ON GLOBAL ADVANCED WOUND CARE MARKET

    • 7.1.1 AFTERMATH OF COVID-19 AND GOVERNMENT ROLE
  • 7.2 STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
  • 7.3 PRICE IMPACT
  • 7.4 IMPACT ON SUPPLY CHAIN
  • 7.5 IMPACT ON DEMAND
  • 7.6 CONCLUSION

8 GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE

  • 8.1 OVERVIEW
  • 8.2 DRESSING
    • 8.2.1 FOAM DRESSING
    • 8.2.2 FILM DRESSING
      • 8.2.2.1 TRANSPARENT
      • 8.2.2.2 NON TRANSPARENT
    • 8.2.3 ALGINATE DRESSING
    • 8.2.4 ANTIMICROBIAL
    • 8.2.5 HYDROGEL DRESSING
    • 8.2.6 COLLAGEN DRESSING
    • 8.2.7 POLYACRYLATE DRESSINGS
    • 8.2.8 SUPER ABSORBENT DRESSING
      • 8.2.8.1 NON- ADHERENT
      • 8.2.8.2 ADHERENT
    • 8.2.9 WOUND CONTACT LAYER
    • 8.2.10 WOUND CLEANSERS
    • 8.2.11 HONEY DRESSINGS
  • 8.3 THERAPY DEVICES
    • 8.3.1 NEGATIVE PRESSURE WOUND THERAPY (NPWT)
      • 8.3.1.1 DISPOSABLE NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES
      • 8.3.1.2 PORTABLE NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES
      • 8.3.1.3 STANDALONE NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES
    • 8.3.2 PHYSICAL THERAPIES
      • 8.3.2.1 LASER THERAPY
      • 8.3.2.2 EXTERNAL SHOCK WAVE THERAPIES
      • 8.3.2.3 ELECTRICAL STIMULATION
      • 8.3.2.4 SALINE MIST THERAPY
    • 8.3.3 PRESSURE RELIEF DEVICES
      • 8.3.3.1 MATTRESS
      • 8.3.3.2 BED
    • 8.3.4 HYPERBARIC OXYGEN CHAMBERS
      • 8.3.4.1 MONOPLACE
      • 8.3.4.2 MULTIPLACE
      • 8.3.4.3 TOPICAL
    • 8.3.5 WOUND DEBRIDEMENT DEVICES
      • 8.3.5.1 ULTRASOUND
      • 8.3.5.2 HYDROSURGICAL
      • 8.3.5.3 MECHANICAL
      • 8.3.5.4 OTHERS
  • 8.4 BIOLOGICS
    • 8.4.1 ALLOGRAFTS
      • 8.4.1.1 CULTURED ALLOGRAFTS
      • 8.4.1.2 HUMAN DERMAL LAYER
    • 8.4.2 XENOGRAFTS
    • 8.4.3 SYNTHETIC SKIN GRAFTS
    • 8.4.4 GROWTH FACTORS
      • 8.4.4.1 PLATELET DERIVED GROWTH FACTORS (PDGF)
      • 8.4.4.2 PLATELET RICH PLASMA (PRP)
      • 8.4.4.3 EPIDERMAL GROWTH FACTORS (EGF)
      • 8.4.4.4 GRANULOCYTE COLONY STIMULATING FACTORS (G-CSF)
      • 8.4.4.5 BASIC FIBROBLAST GROWTH FACTORS (BFGF)
      • 8.4.4.6 KERATINOCYTE GROWTH FACTORS (KGF)
      • 8.4.4.7 TALACTOFERRIN ALFA
      • 8.4.4.8 THROMBIN PEPTIDE (TP508)
  • 8.5 OTHERS

9 GLOBAL ADVANCED WOUND CARE MARKET, BY WOUND CLASS

  • 9.1 OVERVIEW
  • 9.2 CLASS III
  • 9.3 CLASS IV
  • 9.4 CLASS II
  • 9.5 CLASS I

10 GLOBAL ADVANCED WOUND CARE MARKET, BY WOUND TYPE

  • 10.1 OVERVIEW
  • 10.2 PRIMARY WOUND CARE
    • 10.2.1 SURGICAL INCISIONS
    • 10.2.2 ULCERS
      • 10.2.2.1 DIABETIC FOOT ULCERS
      • 10.2.2.2 PRESSURE ULCERS
      • 10.2.2.3 VENOUS ULCERS
    • 10.2.3 PAPER CUTS
    • 10.2.4 SMALL CUTANEOUS WOUNDS
  • 10.3 SECONDARY WOUND CARE
    • 10.3.1 TRAUMATIC WOUNDS
    • 10.3.2 BURNS
      • 10.3.2.1 THERMAL BURN
      • 10.3.2.2 ELECTRICAL BURN
      • 10.3.2.3 CHEMICAL BURN
      • 10.3.2.4 RADIATION BURN
      • 10.3.2.5 FRICTION BURN

11 GLOBAL ADVANCED WOUND CARE MARKET, BY END USER

  • 11.1 OVERVIEW
  • 11.2 HOPSITALS
  • 11.3 WOUND CARE CENTERS
  • 11.4 AMBULATORY CENTERS
  • 11.5 HOME HEALTH CARE
  • 11.6 CLINICS
  • 11.7 OTHERS

12 GLOBAL ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL

  • 12.1 OVERVIEW
  • 12.2 DIRECT TENDERS
  • 12.3 RETAIL

13 GLOBAL ADVANCED WOUND CARE MARKET, BY GEOGRAPHY

  • 13.1 OVERVIEW
  • 13.2 NORTH AMERICA
    • 13.2.1 U.S.
    • 13.2.2 CANADA
    • 13.2.3 MEXICO
  • 13.3 EUROPE
    • 13.3.1 GERMANY
    • 13.3.2 FRANCE
    • 13.3.3 U.K.
    • 13.3.4 ITALY
    • 13.3.5 SPAIN
    • 13.3.6 RUSSIA
    • 13.3.7 NETHERLANDS
    • 13.3.8 SWITZERLAND
    • 13.3.9 BELGIUM
    • 13.3.10 TURKEY
    • 13.3.11 REST OF EUROPE
  • 13.4 ASIA-PACIFIC
    • 13.4.1 JAPAN
    • 13.4.2 CHINA
    • 13.4.3 AUSTRALIA
    • 13.4.4 SOUTH KOREA
    • 13.4.5 INDIA
    • 13.4.6 INDONESIA
    • 13.4.7 THAILAND
    • 13.4.8 SINGAPORE
    • 13.4.9 MALAYSIA
    • 13.4.10 PHILIPPINE
    • 13.4.11 REST OF ASIA-PACIFIC
  • 13.5 SOUTH AMERICA
    • 13.5.1 BRAZIL
    • 13.5.2 ARGENTINA
    • 13.5.3 REST OF SOUTH AMERICA
  • 13.6 MIDDLE EAST & AFRICA
    • 13.6.1 SOUTH AFRICA
    • 13.6.2 SAUDI ARABIA
    • 13.6.3 UAE
    • 13.6.4 EGYPT
    • 13.6.5 ISRAEL
    • 13.6.6 REST OF MIDDLE EAST & AFRICA

14 GLOBAL ADVANCED WOUND CARE MARKET: COMPANY LANDSCAPE

  • 14.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 14.3 COMPANY SHARE ANALYSIS: EUROPE
  • 14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

15 SWOT ANALYSIS

16 COMPANY PREFOLE

  • 16.1 SMITH & NEPHEW
    • 16.1.1 COMPANY SNAPSHOT
    • 16.1.2 REVENUE ANALYSIS
    • 16.1.3 COMPANY SHARE ANALYSIS
    • 16.1.4 PRODUCT PORTFOLIO
    • 16.1.5 RECENT DEVELOPMENTS
  • 16.2 3M
    • 16.2.1 COMPANY SNAPSHOT
    • 16.2.2 REVENUE ANALYSIS
    • 16.2.3 COMPANY SHARE ANALYSIS
    • 16.2.4 PRODUCT PORTFOLIO
    • 16.2.5 RECENT DEVELOPMENT
  • 16.3 MEDLINE INDUSTRIES, INC.
    • 16.3.1 COMPANY SNAPSHOT
    • 16.3.2 COMPANY SHARE ANALYSIS
    • 16.3.3 PRODUCT PORTFOLIO
    • 16.3.4 RECENT DEVELOPMENTS
  • 16.4 MOLNLYCKE HEALTH CARE AB
    • 16.4.1 COMPANY SNAPSHOT
    • 16.4.2 COMPANY SHARE ANALYSIS
    • 16.4.3 PRODUCT PORTFOLIO
    • 16.4.4 RECENT DEVELOPMENTS
  • 16.5 CONVATEC GROUP PLC
    • 16.5.1 COMPANY SNAPSHOT
    • 16.5.2 REVENUE ANALYSIS
    • 16.5.3 PRODUCT PORTFOLIO
    • 16.5.4 RECENT DEVELOPMENTS
  • 16.6 BAXTER
    • 16.6.1 COMPANY SNAPSHOT
    • 16.6.2 REVENUE ANALYSIS
    • 16.6.3 PRODUCT PORTFOLIO
    • 16.6.4 RECENT DEVELOPMENTS
  • 16.7 CARDINAL HEALTH
    • 16.7.1 COMPANY SNAPSHOT
    • 16.7.2 REVENUE ANALYSIS
    • 16.7.3 PRODUCT PORTFOLIO
    • 16.7.4 RECENT DEVELOPMENTS
  • 16.8 B. BRAUN MELSUNGEN AG
    • 16.8.1 COMPANY SNAPSHOT
    • 16.8.2 REVENUE ANALYSIS
    • 16.8.3 PRODUCT PORTFOLIO
    • 16.8.4 RECENT DEVELOPMENTS
  • 16.9 BRIGHTWAKE LTD.
    • 16.9.1 COMPANY SNAPSHOT
    • 16.9.2 PRODUCT PORTFOLIO
    • 16.9.3 RECENT DEVELOPMENT
  • 16.10 COLOPLAST GROUP
    • 16.10.1 COMPANY SNAPSHOT
    • 16.10.2 REVENUE ANALYSIS
    • 16.10.3 PRODUCT PORTFOLIO
    • 16.10.4 RECENT DEVELOPMENTS
  • 16.11 DERMARITE INDUSTRIES, LLC
    • 16.11.1 COMPANY SNAPSHOT
    • 16.11.2 PRODUCT PORTFOLIO
    • 16.11.3 RECENT DEVELOPMENT
  • 16.12 ELKEM ASA
    • 16.12.1 COMPANY SNAPSHOT
    • 16.12.2 REVENUE ANALYSIS
    • 16.12.3 PRODUCT PORTFOLIO
    • 16.12.4 RECENT DEVELOPMENTS
  • 16.13 ESSITY AKTIEBOLAG
    • 16.13.1 COMPANY SNAPSHOT
    • 16.13.2 REVENUE ANALYSIS
    • 16.13.3 PRODUCT PORTFOLIO
    • 16.13.4 RECENT DEVELOPMENTS
  • 16.14 HOLLISTER INCORPORATED
    • 16.14.1 COMPANY SNAPSHOT
    • 16.14.2 PRODUCT PORTFOLIO
    • 16.14.3 RECENT DEVELOPMENTS
  • 16.15 INTEGRA LIFESCIENCES CORPORATION
    • 16.15.1 COMPANY SNAPSHOT
    • 16.15.2 REVENUE ANALYSIS
    • 16.15.3 PRODUCT PORTFOLIO
    • 16.15.4 RECENT DEVELOPMENTS
  • 16.16 JOHNSON & JOHNSON SERVICES, INC.
    • 16.16.1 COMPANY SNAPSHOT
    • 16.16.2 REVENUE ANALYSIS
    • 16.16.3 PRODUCT PORTFOLIO
    • 16.16.4 RECENT DEVELOPMENT
  • 16.17 KERECIS
    • 16.17.1 COMPANY SNAPSHOT
    • 16.17.2 PRODUCT PORTFOLIO
    • 16.17.3 RECENT DEVELOPMENTS
  • 16.18 LOHMANN & RAUSCHER GMBH & CO. KG
    • 16.18.1 COMPANY SNAPSHOT
    • 16.18.2 PRODUCT PORTFOLIO
    • 16.18.3 RECENT DEVELOPMENTS
  • 16.19 MEDTRONIC
    • 16.19.1 COMPANY SNAPSHOT
    • 16.19.2 REVENUE ANALYSIS
    • 16.19.3 PRODUCT PORTFOLIO
    • 16.19.4 RECENT DEVELOPMENT
  • 16.20 MIMEDX
    • 16.20.1 COMPANY SNAPSHOT
    • 16.20.2 REVENUE ANALYSIS
    • 16.20.3 PRODUCT PORTFOLIO
    • 16.20.4 RECENT DEVELOPMENTS
  • 16.21 ORGANOGENESIS INC.
    • 16.21.1 COMPANY SNAPSHOT
    • 16.21.2 REVENUE ANALYSIS
    • 16.21.3 PRODUCT PORTFOLIO
    • 16.21.4 RECENT DEVELOPMENTS
  • 16.22 HARTMANN USA, INC. (A SUBSIDIARY OF PAUL HARTMANN AG)
    • 16.22.1 COMPANY SNAPSHOT
    • 16.22.2 REVENUE ANALYSIS
    • 16.22.3 PRODUCT PORTFOLIO
    • 16.22.4 RECENT DEVELOPMENTS
  • 16.23 TRIAGE MEDITECH PVT. LTD.
    • 16.23.1 COMPANY SNAPSHOT
    • 16.23.2 PRODUCT PORTFOLIO
    • 16.23.3 RECENT DEVELOPMENT
  • 16.24 ZIMMER BIOMET
    • 16.24.1 COMPANY SNAPSHOT
    • 16.24.2 REVENUE ANALYSIS
    • 16.24.3 PRODUCT PORTFOLIO
    • 16.24.4 RECENT DEVELOPMENT

17 QUESTIONNAIRE

18 RELATED REPORTS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.